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Small-molecule based fluorescent probes are increasingly important for the detection and imaging of
biological signaling molecules due to their simplicity, high selectivity and sensitivity, whilst being non-
invasive, and suitable for real-time analysis of living systems. With this perspective we highlight sensing
mechanisms including Förster resonance energy transfer (FRET), intramolecular charge transfer (ICT),
photoinduced electron transfer (PeT), excited state intramolecular proton transfer (ESIPT), aggregation
induced emission (AIE) and multiple modality fluorescence approaches including dual/triple sensing
mechanisms (DSM or TSM). Throughout the perspective we highlight the remaining challenges and
suggest potential directions for development towards improved small-molecule fluorescent probes
suitable for biosensing.1. Introduction
The dynamic chemical diversity of the numerous elements, ions
and molecules that constitute the basis of life provides wide
challenges and opportunities for research. Due to their high levels
of sensitivity, fast response time, and technical simplicity, small
molecule based uorescent probes have been widely developed
and applied to the detection of many biologically important ana-
lytes.1–10 In particular, uorescent probes for biologically and/or
environmentally important cations, anions, small neutral mole-
cules, and biological macromolecules (such as protein and DNA)
have been developed to complement the rapid development of
microscopic imaging technologies. As such, uorescent probes
have been extensively used in diverse elds such as biology,
physiology, medicine, pharmacology, and environmental sciences.
Such probes exhibit changes in uorescence intensities or emis-
sion wavelengths through one or more sensing mechanisms,
including Förster resonance energy transfer (FRET),11 intra-
molecular charge transfer (ICT),1 photoinduced electron transfer
(PeT),12 excited state intramolecular proton transfer (ESIPT),13
aggregation induced emission (AIE),14,15 or involve dual/triple
sensing mechanisms (DSM or TSM) (Scheme 1).16 Importantly,
the number of uorescence based systems continues to expand
exponentially, in order to keep pace with the ever expanding uo-
rescence imaging modalities, including super-resolution-based
technologies such as Stochastic Optical Reconstruction Micros-
copy (STORM),17 PALM (photoactivated localization microscopy)18
and super-resolution photoacoustic imaging (PAI).19–21th, Bath, BA2 7AY, UK. E-mail: lw960@
bath.ac.uk
ring, Henan Normal University, Xinxiang
ly to this work.
26An ideal uorescence sensing system provides a reliable
output response under analytical conditions which relates
directly to the concentration of the analyte present. SuchScheme 1 Schematic representation of the fluorescent mechanisms
discussed in this perspective.
© 2021 The Author(s). Published by the Royal Society of Chemistry
Fig. 1 The mechanism of Förster resonance energy transfer (FRET). R
is the distance between the energy donor and acceptor, J(l) repre-
sents the degree of spectroscopic overlap between the donor emis-
sion and the acceptor absorption. Reproduced with permission from

























































































View Article Onlineinteractions can be reversible (the probe being described as
a “chemosensor”) providing an accurate reection of analyte
concentration that may change over time. If the interaction
process is irreversible (the probe being given the term “che-
modosimeter”) the response will indicate only the maximum
concentration of analyte present. Importantly, for uorescent
systems, the nature of the probe's response can also vary. In
particular a turn-on uorescence response upon analyte detec-
tion is desired, to differentiate the response from environ-
mental quenching effects. Likewise, the use of turn on/off
uorescent probes that exhibit only a single emission
maximum for quantifying target analytes may be fraught with
difficulties due to interference from various analytically unre-
lated factors. Instruments' parameters, the microenvironment
around the probe molecule, etc. can all interfere with the
analysis.22 Signicantly, by taking the advantage of the ratio-
metric approach these problems can be successfully overcome.
The ratiometric uorescence response depends on the intensity
change of two or more emission bands of a probe species before
and aer the analyte recognition event. As such, it provides an
effective internal reference that signicantly improves sensi-
tivity and quantication.
Amongst organic uorescent probes, near-infrared (NIR,
650–900 nm) probes have proven to be especially advantageous
when used in vivo or in vitro.23–26 Such probes allow for deep-
tissue penetration, reduce interference from haemoglobin and
water,27 and lessen the risk of photobleaching due to the lower
energy of excitation required.28 Furthermore, autouorescence
of endogenous species is reduced since such species usually
absorb or emit below 600 nm.29 The use of two-photon (TP)
excitation, rst described by Webb et al. in 1990,30 has been
widespread in the world of NIR uorescent probes.31,32 TP
excitation occurs when two (typically NIR) photons of similar
energy are absorbed by a molecule, and the combined energies
promote it to an excited state suitable for uorescence emis-
sion.33 TP uorescence has the same advantages as NIR uo-
rescence, but in addition can generate uorescence emissions
in the visible region. Furthermore, it allows for specic local-
isation of excitation, since the absorption of two photons only
happens within the focal plane, therefore potentially reducing
photodamage.34 However, some evidence suggests that use of
TPM for biological imaging can in fact lead to greater photo-
bleaching (in comparison to single photon experiments),
dependent on the power level at which the imaging is per-
formed.35 However, the extent of photobleaching can be mini-
mised by use of higher pulse repetition rates in preference to
a continuous laser source.36
In this perspective, we will highlight the features of uo-
rescent probes that use a variety of different uorescence
mechanisms, with a focus on those that have shown promise in
the realms of biological sensing and imaging. Moreover, we will
highlight how uorescent probes with optimized optical prop-
erties are powerful tools for biological research. For example,
NIR emission and TP probes are useful to image target analytes
in deep tissues. Aer detailing prominent examples using each
uorescence technique, a consideration of the advantages and
disadvantages of that mode of uorescence is also presented.© 2021 The Author(s). Published by the Royal Society of Chemistry2. Förster resonance energy transfer
(FRET) probes
Förster resonance energy transfer (FRET) is a non-radiative
process in which excited dye donors transfer energy to ground
state dye acceptors through a long range dipole–dipole inter-
action (Fig. 1).37 The donor moiety absorbs higher energy,
shorter wavelength light, whereas the acceptor absorbs and
emits lower energy, longer wavelength light. Considerations for
designing FRET-based probes include: (1) the donor–acceptor
pair should be within 10–100 A of each other, (2) emission
spectrum of the donor and the absorption spectrum of the
acceptor should overlap, (3) donor emission moment, acceptor
absorption moment, and the separation vector should be
favourably oriented. At this point readers are directed to
a recent review by James et al. covering FRET-based small-
molecule uorescent probes for the detection or imaging of
cations, anions, small neutral molecules, biomacromolecules,
cellular microenvironments and dual/multi-analyte responsive
systems.11
Han et al. have developed a ratiometric probe ThioRB-FITC-
MSN for sensing lysosomal hypochlorous acid (HOCl).38 The
probe is composed of silica nanoparticles with a uorescein
uorophore as the donor dye and a non-uorescent spi-
rothioether unit which reacts with HOCl to generate a uores-
cent rhodamine as the acceptor dye. ThioRB-FITC-MSN has an
emission maximum at lem ¼ 526 nm (lex ¼ 490 nm). In the
presence of HOCl, an increase in emission at lem ¼ 586 nm
accompanied by decreased emission at lem ¼ 526 nm occurs,
which was attributed to the HOCl-triggered tandem oxidation
and b-elimination of the spirothioether-bearing unit to produce
rhodamine, facilitating FRET from the uorescein donor to the
rhodamine acceptor and emission at lem ¼ 586 nm (Scheme 2).
ThioRB-FITC-MSN exhibited good selectivity towards HOCl overChem. Sci., 2021, 12, 3406–3426 | 3407
Scheme 2 FRET-based ratiometric fluorescent probe ThioRB-FITC-

























































































View Article Onlineother reactive oxygen and nitrogen species (ROS/RNS) including
nitric oxide (NO), H2O2, cOH, ROOc or O2c
. Furthermore, aer
L929 cells were stained with ThioRB-FITC-MSN and Lyso-
Tracker Blue DND-22 (a lysosome marker), L929 cells exhibited
excellent uorescence co-localisation of the probe and Lyso-
Tracker Blue, which indicated that ThioRB-FITC-MSN was
suitable for targeting the lysosomes of L929 cells.
Qian et al. have developed a FRET-based small molecule
uorescent probe PNCy3Cy5 for the selective detection of per-
oxynitrite (ONOO) in living cells.39 The cyanine dyes Cy3 and
Cy5 are bright and photostable, and are well suited for the
uorescence imaging of living cells. PNCy3Cy5 contains a Cy3
and Cy5 dyad which serves as the uorescence energy donor
and acceptor pair separated by an acetyl–piperazinyl–hexanoyl
spacer that tethers the Cy3 and Cy5 together (Scheme 3).
PNCy3Cy5 displays uorescence emission for Cy5 (lex ¼Scheme 3 Cy3 and Cy5 (energy donor and acceptor)-based FRET
fluorescent probe PNCy3Cy5, developed for the ratiometric detection
of ONOO. Also shown is the structure of its cleavage product PNCy3.
3408 | Chem. Sci., 2021, 12, 3406–3426530 nm, lem ¼ 660 nm) due to FRET from Cy3. However, in the
presence of ONOO, the Cy5 moiety was selectively oxidised to
its oxindole derivative, terminating the FRET process, resulting
in a uorescence increase at lem¼ 560 nm and a decrease at lem
¼ 660 nm, the uorescence intensity ratio I560nm/I660nm dis-
playing a nearly 324-fold enhancement. The proposed cleavage-
based mechanism of action was supported by mass spectro-
metric analyses, which conrmed the formation of the oxidized
product PNCy3. Furthermore, PNCy3Cy5 exhibits an excellent
detection limit of 0.65 nM and high detection selectivity in
0.1 M phosphate buffer (0.2% DMF, v/v, pH ¼ 7.4). Inspired by
these results, PNCy3Cy5 was used as a ratiometric sensor for
both exogenous and endogenous uorescence imaging of
ONOO in RAW264.7 macrophages.
Chang et al. have reported a TP ratiometric uorescent probe
MITO-CC based on FRET for the detection of mitochondrial
ONOO.40 MITO-CC combined a modied chromenylium uo-
rophore as the energy acceptor and a modied coumarin as the
energy donor (Scheme 4). In the absence of ONOO, MITO-CC
exhibited a strong emission at 651 nm and a weak emission of
coumarin at 473 nm. Upon addition of ONOO (0 to 7.5 mM),
a 93-fold uorescence ratio (I473nm/I651nm) enhancement was
reported. Furthermore, a low limit of detection (LoD, 11.3 nM),
fast response (less than 20 s) and high selectivity over other
biological ROS/RNS including NO, NO2
, H2S, H2S2, HNO, H2O2
and HOCl in PBS buffer solution (25 mM, containing 30%
ethanol, pH 7.4) were observed. Moreover, the low cytotoxicity of
MITO-CC facilitated the monitoring of endogenous ONOO in
HepG2/RAW264.7 cells and an LPS-stimulated mouse model.
Chang et al. have developed a novel FRET-based ratiometric
uorescent probe FIP-1 for the detection of ferrous cation (Fe2+)
in living systems.41 FIP-1 links a 5-aminomethyl uorescein (5-
AMF) donor and a cyanine 3 (Cy3) acceptor through an endo-
peroxide bridge as a Fe2+ responsive trigger (Scheme 5). TheScheme 4 FRET-based ratiometric fluorescent probe MITO-CC for
the detection of ONOO.
© 2021 The Author(s). Published by the Royal Society of Chemistry

























































































View Article Onlineinitial state of probe FIP-1 is FRET on, with emissions at 515 nm
and 556 nm, when excited at 488 nm. However, with the addi-
tion of Fe2+ the endoperoxide core can be cleaved, which leads
to dissociation of the donor and acceptor, resulting in FRET
turn off. This leads to increased emission at 515 nm and loss at
emission at 556 nm, corresponding to the emission of the 5-
AMF donor. FIP-1 exhibited high selectivity and sensitivity
towards Fe2+ over other competing biologically relevant metals
such as Fe3+, Cu2+ and Zn2+, facilitating the imaging of labile
iron pools in HEK 293T cells.
Reactive sulfur species (RSS) have become an important
research area due to their vital physiological functions. Among
the RSS, hydrogen sulde (H2S) is perhaps the most attractive to
study, since changes in H2S metabolism can lead to an array of
pathological disturbances in the form of hypertension, athero-
sclerosis, heart failure, and diabetes.42,43 In 2019, Zhang et al.
developed a single dual-reactive FRET-based uorescent probe
N3-CR-PO4 for monitoring how phosphatase activity depends
on the levels of H2S in cells. The FRET system consists of an N3-
modied coumarin and phosphate-modied rhodol, connected
by a piperazine bridge.44 The proposed sensing mechanism is
depicted in Scheme 6. Initially, N3-CR-PO4 exhibits relativelyScheme 6 FRET-based N3-CR-PO4 developed for the detection of H2S
© 2021 The Author(s). Published by the Royal Society of Chemistryweak uorescence peaks at 445 and 545 nm upon excitation at
360 nm in Tris–HCl buffer (pH 7.2). However, upon addition of
H2S, a blue uorescence at lem ¼ 445 nm (lex ¼ 360 nm) was
observed due to the reduction of the –N3 to –NH2. Subsequently,
on the addition of alkaline phosphatase (ALP), the phosphate
group of N3-CR-PO4 was cleaved, leading to recovery of the
green uorescence at lem ¼ 545 nm (lex ¼ 510 nm) of rhodol in
Tris–HCl buffer (pH 8.0). In the presence of xed concentra-
tions of H2S followed by addition of ALP, the uorescence at lem
¼ 445 nm decreased gradually, and the uorescence at lem ¼
545 nm signicantly increased, due to FRET from the donor
(coumarin) to the acceptor (rhodol). Furthermore, N3-CR-PO4
was shown to have high selectivity for ALP over other enzymes,
amino acids, proteins, peptides, and inorganic salts. Impor-
tantly, it was conrmed in HeLa cells that intracellular
concentrations of H2S exhibited a crucial role in regulating the
activity of the phosphatase enzyme. It was found that cells can
regulate their H2S concentrations in order to maintain an
optimal level of phosphatase activity.
b-Secretase (BACE1) is an important enzyme in Alzheimer's
disease (AD).45 b-amyloid (Ab) peptides are generated by
sequential cleavages from BACE1, and the accumulation of Ab isand phosphatase.
Chem. Sci., 2021, 12, 3406–3426 | 3409
Scheme 7 Illustration for the working principle of the designed TP
ratiometric fluorescent probe AF633mCyd, for the determination of
BACE1 in neurons and mouse brain tissue slice. Reproduced with


























































































View Article Onlineresponsible for the pathogenesis of AD.46 Recently, Tian and
colleagues have created a FRET-based TP ratiometric uores-
cent probe AF633mCyd for the bioimaging and sensing of
BACE1 in different regions of ADmouse brain. The FRET system
contains an acceptor – Alexa Fluor 633 (AF633) and a donor –
merocyanine derivative (mCyd) which are connected by a linker
that is a substrate of the enzyme, with a chain length less than
10 nm, as shown in Scheme 7.47 The peptide substrate (EVNL-
DAEFRHDSGYK) was inserted between the donor and
acceptor, then because the linker can be specically cleaved by
BACE1 the donor and acceptor are separated. The sensing
mechanism was conrmed using mass spectrometry. AF633m-
Cyd exhibited a maximum emission at 651 nm upon TP exci-
tation at 820 nm, which was ascribed to the emission prole of
the uorescent acceptor AF633. Exposure of AF633mCyd to
BACE1 results in the separation of the donor and acceptor in
this system which caused a reduction in the AF633-based uo-
rescence emission at 651 nm and an increase in mCyd-based
uorescence emission at 578 nm. Importantly, AF633mCyd
displayed high selectivity and sensitivity, as well as good
biocompatibility and long-term stability, facilitating its appli-
cation for the bioimaging and sensing of BACE1 in live neurons
and different regions of AD mice brains. The uorescence
emission ratio of AF633mCyd displayed good linearity with
concentrations of BACE1 from 0.1 to 40.0 nM providing a LoD of
65.3  0.1 pM (fresh cell lysates containing 0.05% DMSO, pH
4.5).
FRET-based uorescent probes are widely used to monitor
cellular dynamics in living cells in real time. Advantages of
FRET-based uorescent probes include large Stokes shis,
ratiometric sensing, and dual/multi-analyte responsive
systems.11 Despite the value of these characteristics, the appli-
cability of FRET is still dependent on the FRET efficiency; the
distance between the donor and acceptor moieties strongly
inuences the efficiency of FRET. Therefore, this technology
still requires further investigation and development. For
instance, combining FRET with advanced uorescence
microscopy techniques, such as uorescence lifetime imaging
microscopy (FRET-FLIM), offers a sensitive method for lifetime
measurements.483410 | Chem. Sci., 2021, 12, 3406–34263. Intramolecular charge transfer
(ICT) probes
A common approach for analyte detection is the use of intra-
molecular (or internal) charge transfer (ICT) probes. Fluo-
rophores of ICT probes are made of 3 conjugated parts – an
electron donor (D), an electron acceptor (A) and p-conjugated
linker.1 When ICT probes interact with the desired analyte, the
electron density in the recognition group is altered (e.g. as
a result of bond cleavage, substitution, or substrate coordina-
tion) which installs a ‘push–pull’ system in the molecule. Exci-
tation of the resultant species, in tandem with the altered
electron distribution, affords a large dipole and altered excited
state to that of the initial probe.49 As such, ICT probes
commonly exhibit a ‘turn-on’ uorescence response and wave-
length shi of the uorescence aer interaction/recognition of
the analyte (though there key instances where ICT probes allow
for a ratiometric analysis, where instead a shi of the uores-
cence response is given).50,51
Use of ICT probes is particularly prevalent for detecting
enzyme activity, especially when coupled with the advantages of
NIR uorescence (e.g. deep tissue penetration, low background
uorescence).52 In 2016, Zhu et al. reported an in vivo NIR probe
to target enzyme b-galactosidase (b-gal), a biomarker for cell
senescence and primary ovarian cancers.53 The probe, DCM-
bgal, was composed of a dicyanomethylene-4H-pyran (DCM)
NIR uorophore connected to a sugar recognition moiety.
Initial evaluation using PBS/DMSO indicated that in the pres-
ence of b-gal, the sugar moiety of DCM-bgal could be cleaved to
release DCM-O (Scheme 8). The process was found produce
a ratiometric (lex ¼ 450 nm, lem ¼ 685 nm and 500 nm) and
turn-on (lex ¼ 535 nm, lem ¼ 685 nm) uorescence response
depending on the excitation wavelength. The response of DCM-
bgal towards b-gal was rapid, with a plateau in uorescence
aer 35 minutes. A detection limit of 1.7  104 U mL1 was
obtained. DCM-bgal was highly selective towards b-gal over
other enzymes (cellulase, reductase, lysozyme, esterase) and
biologically relevant species (Cys, Hcy, GSH, H2O2, H2S,
dithiothreitol). DCM-bgal could be used to visualise 293T
(human embryonic kidney) cells. Specically, 293T cells withScheme 8 Detection mechanism of probe DCM-bgal towards b-gal.

























































































View Article Onlinethe lacZ gene (i.e., over expressing b-gal) resulted in a uores-
cence decrease of the green channel (lem ¼ 490–530 nm) and
increase in the red channel (lem ¼ 650–720 nm). Conversely,
293T cells lacking lacZ displayed uorescence predominantly in
the green channel over the red channel. A 5-fold increase in the
ratiometric uorescent response was measured when the lacZ
gene was present. Finally, DCM-bgal was evaluated in tumour-
bearing mice; uorescence was observed within 5 minutes of
DCM-bgal injection. This work reports the rst real-time in vivo
3D imaging of b-gal.
A family of enzymes that have received signicant attention
are the cytochrome P450 (CYP) enzymes.54,55 In 2019, Ma et al.
described a probe to determine the catalytic activity of CYP450,
and in particular the isoform CYP2J2, a potential cancer
biomarker involved in cell proliferation, angiogenesis, and
metastasis.56,57 Like CYP1A, CYP2J2 effects o-dealkylation of its
substrates. The HXPI uorophore was selected based on its
good tissue penetration, low cytotoxicity, and the exibility of
the molecule favouring binding in the active site of CYP2J2.
Initial screening of the recognition moieties indicated that o-
methylatedHXPI,MXPI, was able to t the active site of CYP2J2,
but metabolism of the recognition group was low. Addition of
the self-immolative p-hydroxybenzyl (PHB) linker was found to
increase metabolism of the probe. In silico studies rationalised
this as being due to the placement of the OMe group closer to
the catalytic site of CYP2J2. Screening a series of o-alkyl recog-
nition moieties found that o-methylation was optimal, overall
affording BnXPI (Scheme 9). In PBS solution (pH 7.4), BnXPI
exhibited a turn-on uorescent response towards CYP2J2 (lex ¼
656 nm, lem ¼ 718 nm), and was found to be highly selective
(46-fold) towards CYP2J2 (detection limit of 0.024 mg mL1)
when compared to other CYP isoforms. Testing of BnXPI in
HLMs showed that the probe could successfully monitor
CYP2J2 activity with calculated metabolic rates comparable to
those of determined using the nonuorescent standard aste-
mizole. NIR uorescence bioimaging of CYP2J2 in cells was
achieved in a range of human cancer cell lines (U251, HepG2,
A549, and K562) within 1 h at physiological pH (lex ¼ 633 nm,
lem ¼ 690–750 nm). Exogenous inhibition of CYP2J2 conrmed
the observed uorescent enhancements were afforded by
CYP2J2. Furthermore, BnXPI was shown to detect angiogenesis
in human umbilical vein endothelial cells (HUVEC) in vivo and
ex vivo; signicant uorescent enhancement was achieved and
neovessel growth could be followed due to the increasedScheme 9 Mechanism of detection of CYP2J2 by probe BnXPI, with initia
shown.
© 2021 The Author(s). Published by the Royal Society of Chemistryexpression of CYP2J2 in such environments. In addition, BnXPI
could be used as a clinical tool for patients with cancer. In
healthy patients, peripheral blood samples treated with BnXPI
showed little uorescence response. Conversely, samples taken
from lymphoma and leukaemia patients showed signicant
uorescent turn-on response, which was found to be propor-
tional to expression of CYP2J2. Finally, it was shown that BnXPI
could be used for real-time in vivo imaging of tumours in mice.
Injection with BnXPI afforded both a rapid (<10 min) and
selective uorescence response localised within the tumour
region.
Another area in which NIR ICT probes have been used is in
the detection of (non-peptidic) biologically relevant small
molecules. One such class of analytes are reactive oxygen
species (ROS), which are associated with oxidative stress and as
a result received much attention in the world of uorescent
probes for biological applications.58,59 In 2019, a TP uorescent
probe for the detection of the ROS hydroxyl radical (cOH) was
developed by Tang et al.60 It is known that cOH can cause
oxidative damage, which has been suggested to contribute to
the pathogenesis of depression. The authors proposed that live
monitoring of cOH in the brain is key to understanding this
relationship, and of all the bioimaging tools two photon
microscopy (TPM) would be the most advantageous. Probe MD-
B incorporated a courmarin 151 (Cou151) uorophore due to its
known TP properties, large Stokes shi, and ICT character. A
pyrazolone was employed as a recognition group for cOH, in
which the electron donor ability of the anilinic nitrogen incor-
porated into the pyrazolone system is attenuated, thereby
masking the inherent ICT system of Cou151. The initial OP (lex
¼ 370 nm, lem ¼ 500 nm) and TP (lex ¼ 800 nm, lem ¼ 500 nm)
experiments in PBS-buffer (pH 7.4) indicated thatMD-B exhibits
a signicant turn-on uorescence response, which scaled line-
arly with cOH. It was proposed that the turn-on response upon
addition of cOH was caused by a single-electron oxidation of
MD-B to form uorescent species MD-B-OH, in which the
Cou151 ICT system is restored (Scheme 10). An increase in
quantum yield (4f ¼ 0.037 to 4f ¼ 0.25 for MD-B and MD-B-OH
respectively) and in TP action cross section (s ¼ 5.0 GM to s ¼
42.6 GM) was observed. MD-B was also found to selectively
detect cOH over all other ROS tested, including O2c
, H2O2,
TBHP, OCl, 1O2, NO, ONOO
, 2,20-azobisisobutyronitrile
(AIBN), 2,20-azobis(2,4-dimethylvaleronitrile) (AMVN), and
CO3c
. A detection limit forMD-B towards cOH was determinedl test compoundMXPI and fluorophoreOXPI (deprotonatedHXPI) also
Chem. Sci., 2021, 12, 3406–3426 | 3411
Scheme 10 Detection of cOH with ICT probe MD-B.

























































































View Article Onlineas 2.4 nM. MD-B was successfully employed to detect cOH in
human astrocytes pre-treated with the cOH inducer glutamate,
in PC12 cells, and in mouse RAW 264.7 cells by TP uorescence
(lem ¼ 400–650 nm). Furthermore, human astrocytes treated
with the cOH scavenger mannitol, as well as glutamate, saw
a signicantly decreased uorescence response. MD-B was
shown to be able to cross the blood–brain barrier and to detect
cOH in the brains of mice under the stress of restraint.
Furthermore, MD-B could actively monitor uctuating levels of
cOH in mice with depression-like behaviour – mice exposed to
chronic unpredictable mild stress (CUMS). Remarkably, TP
images of the brains of CUMS mice indicated a signicant (6-
fold) turn-on uorescence in contrast to control mice. It was
hypothesised that MD-B could be used to evaluate the connec-
tion between cOH and SIRT1, an acetylase enzyme associated
with depression. Through a combination of cOH inhibition and
induction experiments in human astrocytes, it was conrmed
that SIRT1 activity was reduced by cOH. Furthermore, LC-MS/
MS proteomic analysis indicated that cOH oxidises the phenyl-
alanine residues in the active site of SIRT1, thereby reducing its
activity. From these results the authors suggested that cOH, due
to its role in stress and SIRT1, must play an important role in
depression.
Also in 2019, Lewis et al. reported an azulene probe for
detection and imaging of ROS, the rst probe employing an
azulene uorophore for uorescence microscopy.61 Here, the
Bpin group was chosen as the receptor motif due to its high
affinity and selectivity for ONOO.62 It was proposed that upon
addition of ONOO, and reaction to give the corresponding
alcohol, the electron-donating –OH group would reinforce the
inherent polarity of the azulene core via an ICT mechanism and
in doing so cause a turn-on uorescence response. Ethyl esters
were incorporated at the 1- and 3-positions to increase the
stability of the probe, overall affording AzuFluor® 483-Bpin.
Upon reaction with H2O2, AzuFluor® 483-Bpin was rapidly
converted to 6-hydroxy species 1 (Scheme 11). As expected,
AzuFluor® 483-Bpin, was found to be non-uorescent, but
underwent a signicant uorescent turn-on in the presence of
ROS as 1 is formed (lex ¼ 350 nm, lem ¼ 483 nm). As expected
AzuFluor® 483-Bpin was found to be highly selective towards
ONOO over other ROS at equivalent concentrations, but also
exhibited a response to H2O2 at higher concentrations. Emis-
sion at lem¼ 483 nm was enhanced with increasing [ONOO] or
[H2O2], with detection limits calculated to be 21.7 nM and 1.723412 | Chem. Sci., 2021, 12, 3406–3426mM respectively. AzuFluor® 483-Bpin was then evaluated as a TP
chemodosimeter for ROS. The maximum TP uorescence
emission was observed at 700 nm for AzuFluor® 483-Bpin,
which upon addition of ONOOwas found to shi to 810 nm. At
810 nm, the TP action cross-section of 1 was found to be s ¼ 3.2
GM. In vitro HeLa cell studies indicated that when excited at
800 nm, the emission intensity of AzuFluor® 483-Bpin +
ONOO increased 4-fold in respect to AzuFluor® 483-Bpin. The
probe was also shown to successfully undergo turn on uores-
cence, and subsequent TPM imaging, of RAW 264.7 cells pre-
treated with inducers of endogenous ROS. Both induction and
inhibition studies conrmed the uorescence response was due
to the interaction of AzuFluor® 483-Bpin and ROS. Finally,
AzuFluor® 483-Bpin was used to successfully image endoge-
nous ONOO and H2O2 in rat hippocampal tissue via TP
microscopy (TPM, lex ¼ 800 nm, lem ¼ 400–600 nm), demon-
strating that AzuFluor® 483-Bpin can detect ROS in tissue.
A class of biomolecules oen studied in tandem with ROS
are biothiols, which commonly act as antioxidants in many
biological systems, as well as being associated with various
disease states (e.g., Alzheimer's disease, liver damage). In 2016,
Lin et al. published an NIR probe able to detect and image
biothiols at both high and low concentrations.63 It was proposed
that use of a single probe with 2 distinct chemical handles
would allow for the detection of multiple biothiol species that
would otherwise require multiple probes, avoiding any associ-
ated issues (e.g. uorescence cross talk, localisation issues). The
probe CHMC-Thiol consisted of chlorohydroxylmerocyanine
(CHMC) NIR uorophore and uses two thiol recognition units.
Each receptor has either ‘high-sensitivity’ (2,4-dini-
trobenzenesulfonate) or ‘low-sensitivity’ (chloride) towards
thiols.
CHMC-Thiol is non-uorescent, but upon addition of low
concentrations of Cys (0–50 mM, 0–10 eq.) a turn-on uores-
cence response was observed (lex ¼ 550 nm, lem ¼ 680 nm).
When CHMC-Thiol was combined with increasing concentra-
tions of Cys (50–500 mM, 10–100 eq.) a ratiometric uorescent
response was observed (lem ¼ I625nm/I680nm). It was proposed
that at low concentrations, Cys attacks the CHMC-Thiol at the
‘high-sensitivity’ sulfonate group to generate the corresponding
uorescent species CHMC1, in which the liberated phenol
moiety creates an ICT system (Scheme 12). Reaction of CHMC-
Thiol with higher concentrations of Cys effects both cleavage of
the ‘high-sensitivity’ recognition moiety, and in addition
substitution of the ‘low-sensitivity’ chloro group attached to the
CHMC core. Initial attack of the thiol in Cys generates inter-
mediate 2 in which Cys is S-linked to the CHMC core, which© 2021 The Author(s). Published by the Royal Society of Chemistry
Scheme 12 High and low concentration of Cys detection pathways of

























































































View Article Onlineundergoes an intramolecular addition–elimination reaction to
afford N-linked 3. CHMC-Thiol could be used to detect Hcy and
GSH. CHMC-Thiol reacts with Hcy to induce a uorescence
response analogous to the reaction with Cys. While with GSH, at
low concentrations a turn-on uorescence at lem ¼ 680 nm was
observed, but at higher concentrations only the thioether
product was formed, and no intramolecular addition/
elimination occurs. This resulted in a 10 nm redshi (lem ¼
690 nm) in uorescence emission. The selectivity of CHMC-
Thiol at both lem ¼ 680 nm and lem ¼ 625 nm was determined.
As expected, the probe exhibited a response towards GSH, Hcy,
and Cys at 680 nm. A mild response was also elicited with Na2S.
All other analytes tested (metal cations, ROS, RNS, and biolog-
ical anions) did not generate a uorescence response.
Conversely, at 625 nm a uorescent response was only observed
for Cys and Hcy. CHMC-Thiol was then evaluated in living cells.
A strong uorescence response was observed in the red channel
(lem ¼ 650–750 nm) for HeLa cells incubated with CHMC-Thiol.
Furthermore, cells treated with exogenous Cys exhibited
signicant uorescence enhancement in the orange channel
(lem ¼ 580–640 nm), as well as uorescence in the red channel.
From these observations, the authors concluded that CHMC-
Thiol gave a turn-on response at low Cys concentrations, and
a ratiometric response at high Cys concentrations. Analogous
results were obtained from imaging experiments using Kunm-
ing mice.
The nal probe to be discussed in this section is the
mitochondria-specic HCN probe developed by Sessler et al. in
2018.64 Whilst HCN is a well-recognized toxin, endogenous HCN
is thought to play a physiological role within neurons. The
probeMRP1was designed using the diethylaminocoumarin ICT
uorophore and a methylenepyrrolidinium recognition unit.
Addition of a para-alkoxy group increased the 4f and a benzyl
chloride group was included to immobilise MRP1 within
mitochondria by reacting with protein thiols. The recognition
unit of MRP1 was found to react with HCN both reversibly and
rapidly to give MRP1-CN, exploiting the nucleophilicity of the
cyanide anion at physiological pH (Scheme 13). In solution
(PBS/MeCN, 1 : 3, v/v, pH 7.4), MRP1 exhibited an a linear,© 2021 The Author(s). Published by the Royal Society of Chemistryratiometric uorescence response (lex ¼ 467 nm, lem ¼ I490nm/
I599nm) upon addition of cyanide, and a detection limit of
65.6 nM. The probe was stable for over 24 h in solution, whilst
time trial experiments indicated the detection of KCN in <1 s.
MRP1 was selective towards cyanide over other relevant anions
(e.g. halides, acetate, sulfate, nitrate, perchlorate and azide).
Furthermore, the probe could be cycled ‘on’ and ‘off’ repeatedly
by sequential addition of cyanide and AgNO3 respectively.
Colocalization experiments with Mitotracker Deep Red
indicated that MRP1 localised in cell mitochondria, with
a Pearson's colocalization coefficient of 0.94. Importantly, it was
retained in mitochondria aer the membrane potential was
destroyed. HepG2 cells incubated with only MRP1 gave no
uorescence in the green channel (lem ¼ 460–530 nm), but
strong emission in the red channel (lem ¼ 575–650 nm). Upon
addition of KCN, uorescence enhancement of the green
channel was observed alongside reduced emission in the red
channel. The green-to-red ratiometric response scaled linearly
when KCN was added. Endogenous HCN studies were per-
formed with neuron-like rat pheochromocytoma cells due to
their natural production of HCN. Within 15 minutes of addition
of MRP1, a strong emission was observed in the green channel
and weak emission in the red channel. A combination of
cyanide stimulation with hydromorphine and quenching with
methemoglobin conrmed that the ratiometric response was
due to endogenous HCN production. Sequential use of hydro-
morphine and methemoglobin indicated thatMRP1 was able to
dynamically respond to changing HCN concentrations. It
should be noted that this is the rst example of a uorescent
HCN probe capable of monitoring endogenous HCN.
ICT probes are oen simple in design, allowing for
straightforward syntheses and clear mechanisms of action upon
formation of the D–p–A system. Once a clear a mechanism of
detection is established (e.g. a turn-on uorescence response or
a ratiometric response), the recognition moieties of ICT probes
can oen be easily substituted for those that detect other
species of interest. As such, ICT systems oen provide
straightforward routes to a family of probes for an array of
analytes. The main limitations of ICT probes are due to the riskChem. Sci., 2021, 12, 3406–3426 | 3413

























































































View Article Onlineof reduced uorescence as a result of aggregate-caused
quenching (ACQ), and that the nature of their uorescence is
dependent on the solvent in which the experiments are per-
formed (due to the corresponding solute–solvate interactions).65
The second of these issues can oen lead to problems when
results from initial organic-solvent based experiments are not
reproducible in in vitro studies in biological media (i.e. buffered
aqueous solutions). Furthermore, the broad emissions oen
exhibited by ICT uorophores can prove troublesome when the
uorophore exhibits a ratiometric response.66MGO.4. Photoinduced electron transfer
(PeT) probes
Photoinduced electron transfer (PeT) is one of the most
important mechanisms for developing uorescent probes and
biosensors. The phenomenon of PeT was rst described in the
1970s.67,68 With PeT systems, the intramolecular transfer of
electrons from the receptor to the uorophore results in uo-
rescence quenching. However, when the receptor binds to its
target, the PeT process is inhibited or completely suppressed,
which means the sensor restores its uorescence (Scheme 14).69
PeT based uorescence probes usually have “turn on” features,
which are conducive to uorescence imaging with high signal-
to-noise ratios.
When a uorophore is excited by an appropriate wavelength
of light, an electron from the highest occupied molecular
orbital (HOMO) is transferred to the lowest unoccupied
molecular orbital (LUMO). If the energy level of the HOMO of
the adjacent receptor group lies between the LUMO and HOMO
of the uorophore, an electron transfers from the HOMO of the
receptor to the HOMO of the uorophore by the action of PeT,
“locking” an electron in the LUMO and quenching the uo-
rescence.70 Alternatively, when the receptor binds to a target, the
energy level of the receptor HOMO is lowered below that of theScheme 14 The mechanism of PeT-based fluorescent probes.
Scheme 15 Frontier orbital explanation for the PeT effect.
3414 | Chem. Sci., 2021, 12, 3406–3426HOMO of the uorophore. As such, the PeT process is blocked,
and the uorescence is restored (Scheme 15).
In 2018, Peng et al. reported a PeT-based endoplasmic
reticulum (ER) targeting TP uorescent probe NI-OPD, for
detecting methylglyoxal (MGO),71 which is associated with dia-
betes and related complications (Scheme 16).72 NI-OPD
contains a 1,8-naphthalimide uorophore, and o-phenylenedi-
amine (OPD) as the MGO recognition unit, with an additional
methyl sulfonamide unit as an ER-targeting group. NI-OPD was
non-uorescent in PBS buffer (10% DMF, pH ¼ 7.4) due to an
“enhanced PeT” process from the OPD unit to the 1,8-naph-
thalimide moiety. Upon the addition of MGO, the dicarbonyl
group of MGO reacted with the OPD group to form a stable
adduct that inhibits PeT and affords a turn-on uorescence (75-
fold) at lem ¼ 460 nm (lex ¼ 380 nm). In addition, NI-OPD
displayed excellent selectivity toward MGO over other alde-
hydes, including formaldehyde, acetaldehyde, benzaldehyde,
glutaraldehyde, glyoxylic acid and o-phthalaldehyde (OPA).
Furthermore, NI-OPD was evaluated in normal, diabetic and
metformin treated diabetic mice to evaluate the difference in
their endogenous MGO concentrations. The research indicated
that NI-OPD could serve as a useful tool for evaluating the
involvement of MGO in ER-associated diseases.
Nitric oxide (NO) is a ubiquitous biological messenger, and
plays an active role in the regulation of various physiological
processes in many biological systems, such as the cardiovas-
cular, immune, and the central and peripheral nervous
systems.73,74 In 2016, Guo et al. developed two uorescent PeT
based NO probes 4 and 5, where an N-benzyl-4-hydroxyaniline
group was attached to a BODIPY uorophore and used as the
NO recognition group (Scheme 17).75 Probe 4 exhibited almost
no uorescence in PBS buffer (20% MeCN, pH 7.4) due to PeT
from the N-benzyl-4-hydroxyaniline group to the excited BOD-
IPY dye. However, under aerobic conditions, upon addition of
NO, PeT was inhibited affording a dramatic uorescence
enhancement (92-fold) at lem ¼ 518 nm (lex ¼ 490 nm). The
introduction of a triphenylphosphonium (TPP) group within
probe 4 afforded the mitochondrial targeting probe 5, which
could specically accumulate in the mitochondria of HeLa cells
and was used to image exogenous NO. Guo and co-workers have
also developed a similar probe 6 (Scheme 17),76 which exhibited
a selective uorescence off–on response towards NO and
ONOO using N-benzyl-4-methoxyaniline as the reaction site© 2021 The Author(s). Published by the Royal Society of Chemistry

























































































View Article Onlinerather than the N-benzyl-4-hydroxyaniline group. The results
indicated that probe 6 exhibits a lower LoD (as low as 0.4 nM)
and higher selectivity for NO than probe 4. Moreover, probe 6
could react with ONOO to produce an o-benzoquinone imine
and induced signicant uorescence enhancement. Probe 6
displayed a signicant uorescence off–on response for both
NO and ONOO in HeLa cells. Furthermore, mitochondria-
targetable derivative probe 7 was developed by attaching a tri-
phenylphosphonium group to probe 6, and was used to detect
NO and ONOO in the mitochondria of HeLa cells.
Hydrogen peroxide (H2O2) plays an important role in cell
growth, proliferation, host defence, immune response, and
signalling pathways under physiological conditions.77 In 2017,
Kumar et al. reported a lysosome targeting PeT-based uores-
cence probe LyNC for the detection of endogenous H2O2 in C6
and BV-2 cellular systems.78 LyNC was constructed using
a catechol unit as response site for H2O2 and a morpholine
moiety as a lysosome targeting group (Scheme 18). LyNC
exhibited weak uorescence in aqueous buffer (0.5% DMSO/
PBS, pH 7.4), due to the PeT effect from the catechol to the
naphthalimide uorophore. However, in the presence of H2O2,
the catechol was oxidised to an o-quinone, which inhibited PeT
thereby facilitating a uorescence enhancement at lem ¼
537 nm (lex ¼ 450 nm). Furthermore, LyNC exhibited highScheme 18 The recognition mechanism of probe LyNC towards
H2O2.
© 2021 The Author(s). Published by the Royal Society of Chemistrysensitivity toward H2O2 with a LoD of 0.22 mM, and excellent
selectivity over other ROS/RNS and biothiols including cysteine,
glutathione and homocysteine. Importantly, LyNC has been
successfully used to detect H2O2 and in rat brain tissues and in
living nematodes.
Duan et al. have developed a receptor-targeted uorescent
“off–on” probe SP1 for the detection and imaging of receptor
protein–tyrosine kinases in vivo and in vitro.79 SP1 was
composed of a sunitinib targeting group, a six-carbon bis(a-
mide) linker and a pyrene uorophore. The authors propose
that the uorescence of SP1 is quenched by dimer formation
and p–p stacking interactions forming between the pyrene
units and the uorescence can be restored by binding of the
sunitinib group with receptor protein–tyrosine kinases (Fig. 2).
Initially, SP1 displayed weak emission at lem ¼ 545 nm (lex ¼
460 nm) in a DMSO/H2O simulated physiological medium. In
the presence of the protein–tyrosine kinase receptor, an “off–
on” uorescence change was observed. SP1 was highly selective
towards protein–tyrosine kinase receptor over other amino
acids, inorganic salts, and other relevant substances. More
importantly, SP1 was used to image tyrosine kinase in chick
embryo chorioallantoic membrane and aHT-29 tumour-bearing
mouse model, indicating that it could be used for real-time
visualisation of tyrosine kinases in tumours.
By using PeT-based uorescent probes, the localization,
distribution and conformational changes of target molecules
can be easily unveiled. When compared to sensors without
uorescence switches, PeT-based probes can easily achieve high
signal-to-noise ratios, which is an essential requirement for
satisfactory in vitro and in vivo uorescence imaging. In addi-
tion, uorescent prodrugs based on PET mechanisms areFig. 2 Schematic diagram of SP1 and in vivo fluorescence imaging of
SP1 in a HT-29 tumour-bearing mouse model via SP1 injection: (a)
0.1 mM, 100 mL; (b) 0.5 mM, 100 mL; (c) 1 mM, 100 mL; (d) 2 mM, 100 mL.
The fluorescence signal was imaged at 500 to 720 nm under excitation
with a 460 nm CW laser (power density of 1 mW cm2). Reproduced
with permission from ref. 79. Copyright 2018 American Chemical
Society.

























































































View Article Onlinesuitable agents for cancer diagnosis and therapy.80 As such, the
precise regulation of PeT processes is an avenue of development
for the future improvement of PeT based prodrugs, which could
improve the therapeutic effects and reduce the side effects in
cancer treatment. However, a common disadvantage of PeT-
based probes is the interference of protons, which also bind
with the coordination site, inhibiting the PeT process, and
enhancing the uorescence.81 While, the development of PeT
probes with lower pKa values can offer a promising pathway for
eliminating such proton interference.Scheme 20 The structures of fluorescent probes NP1, NP2, NP3 and
NP4.5. Excited state intramolecular proton
transfer (ESIPT) probes
The excited state intramolecular proton transfer (ESIPT) process
was rst reported by Weller in the 1950s.82 In general, ESIPT
refers to the transfer of hydrogen atoms (mainly from hydroxyl
or amino groups) to nearby heteroatoms (mainly N, O or S)
under excitation.83 Fluorophores with ESIPT properties can
establish a fast four-level photocycle between keto and enol
isomers under excitation.13 ESIPT uorophores, in the elec-
tronic ground state, usually exist in the enol (E) form. Upon
photoexcitation, the electronic charge of the molecule is redis-
tributed, leading to greater acidity of the hydrogen bond donor
group and increased basicity of the hydrogen bond acceptor
within the E form. Therefore, an extremely fast enol to keto
phototautomerization (KESIPT > 10
12 s1) occurs: the excited
state enol (E*) is rapidly converted to the excited ketone (K*).
Aer a radiative decay pathway to the electronic ground state,
a reverse proton transfer (RPT) takes place to produce the
original E form (Scheme 19). The remarkable characteristics ofScheme 19 Diagrammatic description of the ESIPT process. Repro-
duced with permission from ref. 13. Copyright 2018, The Royal Society
of Chemistry.
3416 | Chem. Sci., 2021, 12, 3406–3426ESIPT uorophores are: large Stokes shi,84 and dual emis-
sion,85,86 which make them attractive units for the construction
of functional uorescent probes.
Li et al. have developed a series of 2-(2-hydroxyphenyl)
benzothiazole-based (HBT-based) ESIPT probes NP1, NP2,
NP3 and NP4 for the detection of ONOO with good specicity,
fast response time, and high sensitivity (Scheme 20).87 NP1
responds rapidly to ONOO producing uorescence enhance-
ments in PBS (pH 7.4), however, it was found to be unstable
when exposed to air, therefore, in order to improve molecular
stability,NP2,NP3 andNP4were developed. The hydroxyl group
of HBT was switched to a N-methyl-p-hydroxyaniline, which
blocked the hydrogen donor of the ESIPT process, and electron-
donating groups (–OCH3) were added to the p-hydroxyaniline
ring in order to make the hydroxyl group more susceptible to
oxidation. Exposure of NP3 to ONOO results in the phenol
group oxidizing to a benzoquinone imine, accompanied by N–
C(sp2) bond cleavage, leading to a signicant increase in the
uorescence intensity (600-fold). Moreover, NP3 was capable of
crossing the blood–brain barrier (BBB) and could be used for TP
uorescence spectroscopy. The maximal TP absorption cross
section of probe NP3 was determined to be 3.6 GM at 820 nm.
This enabled probe NP3 to be used to visualize ONOO in
neurovascular ischemia progression in the brains of live mice.
The excellent properties ofNP3 indicate that it could be used for
visualizing other pathophysiological processes associated with
ONOO.
James and co-workers have developed an ESIPT-based
ratiometric uorescent probe ABAH-LW that facilitates the
detection of ONOO (Scheme 21).88 ABAH-LW was able to detect
ONOO within seconds and exhibits good selectivity and
sensitivity towards ONOO over other ROS and biologically
relevant analytes. Initially, the benzyl boronic ester ‘‘protecting’’
unit of ABAH-LW blocks the ESIPT process. On exposure of
ABAH-LW to ONOO, oxidative deprotection of the benzyl
boronic ester unit occurs and leads to a ratiometric uorescence
response (I481nm/I405nm) with signicant uorescence enhance-
ment (103-fold) in PBS buffer (8% DMSO, 1 mM CTAB, pH 8.2).
Furthermore, the reactive chloroacetamide functional group of© 2021 The Author(s). Published by the Royal Society of Chemistry
Scheme 21 The structures of fluorescent probes ABAH-LW and
TCBT-OMe.

























































































View Article OnlineABAH-LW enables covalent attachment to biomacromolecules
located at the ER enabling the visualization of ONOO within
the ER. ABAH-LW was shown to be cell permeable, which
enabled it to be used to visualize ONOO in live HeLa cells. The
same group also developed a HBT-based uorescent probe
TCBT-OMe for the detection of HOCl/ClO (Scheme 21).89 The
presence of HClO/ClO leads to the hydrolysis of the dime-
thylthiocarbamate moiety resulting in a large increase in uo-
rescence intensity (42 fold) at lem ¼ 472 nm (lex ¼ 310 nm).
Probe TCBT-OMe was shown to have high sensitivity (LoD ¼
0.16 nM) and selectivity towards HClO/ClO over other ROS/
RNS and can be used to detect endogenous and exogenous
HClO/ClO in HeLa cells. In addition, test strips containing
TCBT-OMe were constructed and could be used to detect HClO/
ClO in drinking water. Furthermore, TCBT-OMe was used as
dual input logic gate for Hg2+ and H2O2. Interestingly, the
addition of Hg2+ alone to TCBT-OMe resulted in a signicant
increase in the uorescence intensity (within 30 min), which is
believed to due to the instability of the dimethylcarbamate
(incorrectly written as dimethylcarbonate in the original paper)
formed from the reaction of TCBT-OMe with Hg2+.
Zhang et al. have developed a novel mitochondria-targeted
HBT-based ESIPT uorescent probe HBTP-mito that facilitates
the detection of ALP.90 HBTP-mito is comprised of the HBT
uorophore and the pyridinium salt as a mitochondrial tar-
geting group (Scheme 22). Initially, the ESIPT process of the
phosphorylated probe is blocked and it exhibits uorescence at
lem ¼ 514 nm. However, in the presence of ALP, hydrolysis ofScheme 22 The structures of fluorescent probe HBTP-mito.
© 2021 The Author(s). Published by the Royal Society of Chemistrythe phosphate ester and cleavage of the P–O bond releases HBT
resulting in ESIPT turn on, and the emission switches from
green (lem ¼ 514 nm) to red (lem ¼ 650 nm, Scheme 22) in TBS
buffer solution (pH 8.0). Probe HBTP-mito exhibited high
sensitivity (LoD ¼ 0.072 mU mL1) and excellent selectivity for
ALP over other anions, and ions. In addition, the I514nm/I650nm
ratiometric response of the enzymatic hydrolysis product pre-
vented uorescence interference from the serum. Therefore, it
could be used for detecting ALP in serum samples. Due to the
low toxicity of HBTP-mito, it was suitable for monitoring ALP
activity in vitro and in vivo and provided a blue-print for con-
structing ratiometric probes with longer wavelength emission
and high sensitivity.
Recently, Feng and co-workers have developed a uorescent
probe CORM3-green based on an ESIPT phthalimide dye for the
detection of CORM-3 in both solution and living systems.91 CO-
Releasing molecules (CORMs) are agents that release and
deliver CO into the cell and can be used to replace the direct use
of CO gas in the treatment of diseases.92 CORM3-green is non-
uorescent, however, upon addition of CORM-3, the nitro
group is reduced into an amino group to form a highly uo-
rescent phthalimide, which emits bright green uorescence at
lem ¼ 503 nm in PBS buffer (0.5% DMSO, pH 7.4) solution due
to the ESIPT process (Scheme 23). Furthermore, CORM3-green
exhibited high sensitivity toward CORM-3 with a LoD of 16 nM,
and excellent selectivity over other anions, metal ions, amino
acids, ROS/RNS and biothiols including cysteine, glutathione
and homocysteine. CORM3-green was evaluated in solution and
in HeLa cells, zebrash, and mice, thus demonstrating its use
as a potentially powerful visualizing agent for biological
applications.
James et al. have reported a series of 3-hydroxyavone (3-HF)
ESIPT boronate-based uorescent probes that exhibit a ratio-
metric response toward ONOO in micellar environmentsScheme 24 ESIPT probes 3-HF-X (X ¼ OMe, Me, H) for detecting
ONOO. The normal (N) and phototautomeric (T*) forms are shown.
Chem. Sci., 2021, 12, 3406–3426 | 3417
Fig. 3 Fluorescence imaging of a brain section of a transgenic mouse
treated with 3-HF-OMe (20 mM) (a) without and (b) with ONOO (30
mM). The excitation/emission wavelengths for the blue (N-state), green
(T*-state), and red (anti-Ab antibody) channels are 404/425475, 404/
500550, and 561/640730 nm, respectively. The white arrows


























































































View Article Online(Scheme 24).93 Probe 3-HF-OMe, is particularly sensitive toward
hydrophobic environments and is able to differentiate between
micellar and aqueous environments. The benzyl boronic ester
‘‘protecting’’ group blocks the ESIPT process, and the group can
be selectively removed by ONOO. Therefore, probe 3-HF-OMe
was found to produce a ratiometric uorescence response when
bound to Ab aggregates (hydrophobic environment) in the
presence of ONOO. To investigate the potential of the probe
for real world applications, uorescence imaging of 3-HF-OMe
exhibited N-state uorescence in mice brain slices (Fig. 3, blue
channel) associated with Ab aggregates as shown by correlation
with anti-Ab42 antibodies (Fig. 3, red channel). Then addition of
ONOO to the brain sections, generated the T* state of 3-HF-
OMe (Fig. 3, green channel), which correlated well with the
antibody uorescence. As such these preliminary biological
imaging experiments indicate how similar but longer wave-
length ESIPT-based probes could be used to monitor brous
proteins/peptides and environmental ROS/RNS. This system
was described by the authors as a “reactive species” and
“environment” based uorescent probe.
Due to the unique transient nature of the four-level photo-
chemical process of ESIPT, the ESIPT emission is highly sensi-
tive to its local surroundings. Moreover, ESIPT uorophores
exhibit unusually large Stokes shis (200 nm), when
compared to traditional uorophores (uorescein, rhodamine,
etc.). This helps avoid unwanted self-reabsorption and inner-
lter effects. The limitation of ESIPT-based uorescent probes
come from the presence of polar and hydrogen bond donor
solvents, which can lead to inhibition of the ESIPT process with
no ketone (K*) emission.13 However, their use in combination
with other uorescence mechanisms will allow the construction
of new probes that overcome the limitations of many current
detection methods, while allowing the development of more
and more practical uorescence-based sensors and imaging
agents.933418 | Chem. Sci., 2021, 12, 3406–34266. Aggregation induced emission
(AIE) probes
Ordinarily, aggregation of uorescent probe molecules is
considered detrimental, resulting in aggregate-caused quench-
ing (ACQ). The ACQ process is oen exacerbated when a probe
has multiple conjugated aromatic rings due to the increased
formation of exciplexes and excimers.94 However, in 2001 the
Tang group reported that 1-methyl-1,2,3,4,5-pentaphenylsilole
exhibited the opposite effect – upon aggregate formation,
a signicant enhancement in photoluminescence was
observed.95 The emission was ascribed to the severe steric
hindrance of the uorophore – since upon aggregation, the
compound was unable to adopt a uniformly planar conforma-
tion. The process was termed ‘aggregation-induced emission’,
and since then the area has expanded exponentially. Further
investigations have elucidated that one common mechanism of
AIE is the restriction of intramolecular motion (RIM).96 Such
probes show negligible uorescence in solution and exhibit
a signicant ‘turn-on’ upon aggregation. Common application
of AIE compounds include use in electroluminescent devices
and use as uorescent sensors and dosimeters.97 In particular,
AIE has been used in the eld of biological uorescence, for
example in cell imaging, tumour imaging, and enzyme detec-
tion.98 Such probes are oen referred to as ‘AIEgens’. The Tang
group have published comprehensive reviews on, and extensive
descriptions of, the AIE phenomenon, in particular their 2015
article ‘Aggregation-Induced Emission: Together We Shine,
United We Soar’.14
In 2019, Tang et al. published an AIE probe for imaging
carbon monoxide (CO).99 Whilst known for its toxicity, CO is
also an endogenous gasotransmitter and is involved in a range
of disease states and biological pathways. The probe, BTCV–CO,
was designed to undergo a Tsuji–Trost reaction in the presence
of CO and Pd2+ (Scheme 25). In solution, BTCV–COwas found to
uoresce at lem z 675 nm. Solution aggregation experiments
with the probe conrmed the AIE characteristics. Mechanisti-
cally, it has been proposed that in solution rapid non-radiative
decay can occur from the singlet excited state, mediated by cis–
trans isomerisation of the trisubstituted alkene. Then, upon
aggregation the isomerisation pathway is hindered. Therefore,
formation of BTIC via the Tsuji–Trost reaction would similarly
prevent this cis–trans isomerisation. Studies in PBS (5% DMSO,Scheme 25 Detection of CO by AIEgen BTCV–CO.

























































































View Article Onlinev/v, pH 7.4) with CO donor [Ru(CO)3Cl2]2 (CORM-2) and PdCl2
conrmed the expected uorescent enhancement. On forma-
tion of BTIC, a new emission band at lem ¼ 546 nm was
observed, facilitating the ratiometric (I546nm/I710nm) detection of
CO. The ratiometric response of BTCV–CO to CO was more
sensitive than just the turn-on response, affording uorescent
enhancements of 39-fold and 17-fold respectively. The ratio-
metric enhancement was found to correlate with increasing
concentrations of CORM-2, which scaled linearly at low
concentrations (1–5 mM). Furthermore, the probe was found to
be selective towards CO over a range of biological analytes
(including ROS, RNS, amino acids, and common anions), and
the detection limit of BTCV–CO towards CO was determined to
be 30.8 nM. Exogenous addition of CO (via CORM-2) to cells
loaded with BTCV–CO conrmed that the cells underwent
uorescent enhancement in the green window (lex ¼ 476 nm,
lem ¼ 500–580 nm) relative to cells loaded with only the probe
which showed weak emission in both the green and red (lem ¼
580–700 nm) windows. Enhancement of the ratiometric
response was found to correlate with the concentration of CO
added. Furthermore, in vivo evaluation conrmed that a signif-
icant uorescent response could be achieved in mice injected
with BTCV–CO + CORM-2 + PdCl2, whereas injection with only
BTCV–CO + PdCl2 resulted in only weak emission.
An extensive area of the NIR AIE literature concerns probes
for tumour sensing and imaging, particularly as contrast
agents.100,101 In 2015, Zhu et al. designed a series of tumour-
targeting probes based on quinoline–malononitrile AIE uo-
rophores conjugated to a range of electron-donating motifs via
thiophene linkers (Fig. 4).102 Probes QM-3 to QM-6 were found
to exhibit NIR AIE behaviour in solution. Notably, increasing
the electron-donating character of the triphenylamine moiety inFig. 4 Structures of AIEgens QM-3–QM-6.
© 2021 The Author(s). Published by the Royal Society of ChemistryQM-3, QM-5, and QM-6 resulted in a redshi of the AIE. A 3,4-
ethylene-dioxythiophene (EDOT) moiety was introduced to
compounds QM-4, QM-5, and QM-6 to tailor the AIE by altering
the donor–p–acceptor system through the resultant change in
conformation. This resulted in increased aggregation control
with the solution-based studies. Imaging of evaporation exper-
iments, to simulate aggregation, revealed that QM-3 adopted
a microrod structure whilst QM-4–QM-6 formed spherical
nanoparticles. The difference in morphology was attributed to
the introduction of the EDOT moiety in the latter species.
Furthermore, the photostability of each species was found to be
z20-fold greater than commercially available dye ICG. QM-5
exhibited the most desirable characteristics and was evaluated
in cells. The probe underwent rapid uptake and spherical
aggregate formation in HeLa cells. Furthermore, QM-5
remained uorescent 24 h aer incubation and was emissive for
twice as many cell passages as the ICG control. In vivo experi-
ments in mice indicated that QM-5 was tumour specic,
affording an AIE response within 30 minutes. Furthermore, the
probe was tumour retentive, remaining in tumour tissue for
24 h. The tumour specicity was ascribed to the enhanced
permeability and retention (EPR) effect afforded by the spher-
ical shaped aggregates. Ex vivo organ imaging of injected mice
indicated that whilst QM-5 aggregated in tumour tissue, it also
aggregated in the liver.
In 2020, Wu et al. designed an NIR probe for the detection of
breast cancer metastasis, combining AIE and multispectral
optoacoustic tomography (MSOT).103 The group used a donor–
p–acceptor system of dihydroxanthene and quinolinium groups
respectively, using a nitroaryl recognition moiety to afford Q-
NO2. Upon reduction of the nitro group by nitroreductase, the
resultant amine undergoes self-immolation of the p-benzyl
moiety to afford phenol Q-OH (Scheme 26). Fluorescent
enhancement occurred at lem ¼ 780 and 922 nm when excited
at lex ¼ 680 and 808 nm respectively due to the formation of
Q-OH aggregates; the uorescence intensity at each emissionScheme 26 Nitroreductase detection mechanism by AIEgen Q-NO2.

























































































View Article Onlineband was found to increase linearly with increasing concen-
trations of nitroreductase. Furthermore, a linear optoacoustic
response with increasing nitroreductase was observed. The
probe was found to be highly selective over a range of relevant
biological analytes, and a detection limit of 0.052 mg mL1
towards nitroreductase was established. For cell testing, 4T1
murine mammary carcinoma cells were chosen due to their
overexpression of nitroreductase. Hypoxic cells, known to
overexpress nitroreductase, stained withQ-NO2 displayed a turn
on-response for both the NIR-I and NIR-II window, compared to
control cells which exhibited minimal uorescence. In addi-
tion, an optoacoustic response that mirrored that of the uo-
rescence response was observed. Q-NO2 was shown to detect
orthotopic and far metastatic tumours in the mouse models
used, with an enhanced NIR-I and NIR-II response relative to
the bioluminescence control. Tumour imaging via the NIR-II
window afforded a clearer image of the tumours due to the
decreased autouorescence. Notably, MSOT imaging of mice
with Q-NO2 was able to effectively monitor both orthotopic
tumour growth and eventual metastasis in 3D.
Ab is another key biological target, due to its role in the
pathogenesis of Alzheimer's disease. In 2019, Zhu et al.
described a new NIR AIE probe for the imaging of Ab plaques.104
The authors sought to design a probe that improved on
commercial probe Thioavin T (ThT), which suffers from
ACQ, low signal-to-noise ratio, and low BBB penetration. Probe
QM-FN-SO3 incorporated the quinoline–malononitrile NIR u-
orophore, to which a conjugated thiophene was attached to
increase lipophilicity and aid BBB penetration. In addition,
a sulfonate group was added to increase water solubility and
generate a ‘uorescence-off’ state when not aggregated (Fig. 5).
Probe QM-FN-SO3 was non-uorescent in water but a turn-on
uorescence response (lex ¼ 500 nm, lem ¼ 720 nm) was
observed as the solubility of the probe decreased and aggrega-
tion began. In PBS solution,QM-FN-SO3 displayed a positive AIE
response to Ab aggregates, for which uorescent enhancement
(blue-shied to lem¼ 665 nm) increased as the concentration of
Ab aggregates increased. Mechanistically, it was proposed that
the N-dimethylamino group acts as a recognition moiety, which
once bound experiences reduced freedom of rotation, affording
a uorescence response. The half-life of QM-FN-SO3 was found
to be z5 that of ThT at z40 min and exhibited a greater
signal-to-noise ratio both in solution and in mouse brain
models evaluated. Furthermore, in vivo evaluation using mouse
models indicated that could QM-FN-SO3 cross the BBB andFig. 5 Structure of AIEgen QM-FN-SO3.
3420 | Chem. Sci., 2021, 12, 3406–3426produce a uorescence response to Ab plaques in the
hippocampus.
An obvious advantage for the AIE strategy is the ability to
overcome the quenching issues presented by ACQ. Further-
more, for turn-on AIEgens, the probe is non-uorescent in
solution. As a uorescent signal is only observed upon aggre-
gation, as such there is no overlap between the signal of the
species involved in the sensing process, and the process is
independent of the probe concentration.94 Due to the size of
their extensive p-systems, some AIEgens can suffer from
increased hydrophobicity, which may lead to issues with
cellular uptake and distribution.1057. Multiple modality fluorescent
probes
Fluorescent chemosensors have been widely applied in diverse
elds such as biology, physiology, medicine, and pharmacology.
Fluorescence output signals can be observed using optical
instruments and even using the naked eye in real-time.16 Fluo-
rescent chemosensors generally exhibit changes in uorescence
intensities and wavelength using various single sensing mech-
anisms, including ICT, PeT, FRET, ESIPT and AIE.12,50,106,107
However, uorescent chemosensors can also be designed based
on dual (or multiple) uorescence mechanisms in order to
deliver diverse uorescence outputs, facilitating the simulta-
neous tracking of multiple analytes or improving the selectivity
and sensitivity for a particular analyte.
H2S and hydrogen polysuldes (H2Sn, n > 1) are endogenous
regulators of many physiological processes,108 and data suggest
that H2Sn might be the main signalling molecules instead of
H2S. In order to reveal the mutual relationship and cellular
cross-talk between H2S and H2Sn in cells, Xian et al. reported
a dual-channel uorescent probe DDP-1 using a rhodol-
coumarin hybrid for visualizing H2S and H2Sn using different
uorescence signals.109 With DDP-1, an azidocoumarin moiety
and phenyl 2-(benzoylthio)benzoate were chosen as the reaction
sites for H2S and H2Sn. When H2Sn reacts with the phenyl-2-
(benzoylthio)benzoate, the green uorescence of rhodol at lem
¼ 542 nm (lex ¼ 360 nm) was observed (Scheme 27). However,
on the addition of H2S, the situation is more complicated since
the reaction between H2S and azides led to the formation of
H2Sn, however, less than 0.5 equivalents of H2Sn are produced
from the reaction of H2S (1 equivalent) and azide, which means
the reaction with H2S produced both the blue coumarin emis-
sion at lem ¼ 445 nm (major) and green rhodol emission at lem
¼ 542 nm (minor) (lex ¼ 360 nm). Therefore, DDP-1 can detect
H2S and H2Sn using these two distinct emission channels. As
such DDP-1 could be used for the detection of H2S and H2Sn in
HeLa cells.
Yin et al. have developed a novel dual-functional uorescent
probe Mito-CM-BP based on an ICT-FRET mechanism for the
simultaneous detection of GSH and SO2 (Scheme 28).110 The
probe consists of an ICT based coumarin–cyanoacetic acid
system as an energy donor and a reaction site for GSH; while the
benzopyrylium unit (BP) can not only serve as an energy© 2021 The Author(s). Published by the Royal Society of Chemistry

























































































View Article Onlineacceptor but also as a sensitive reaction site for SO2. Two exci-
tation wavelengths at lex ¼ 488 and lex ¼ 405 nm, which
correspond to CM (donor of FRET-I) and CM-GSH (donor of
FRET-II), were chosen as there are two different FRET systems
before and aer Mito-CM-BP reacts with GSH. The free probe
Mito-CM-BP displayed a uorescence emission at lem ¼ 638 nm
(lex ¼ 488 nm). Then upon addition of SO2, the FRET-I process
of Mito-CM-BP was blocked, and the uorescence emission atScheme 28 ICT and FRET-based probe Mito-CM-BP developed to allow
© 2021 The Author(s). Published by the Royal Society of Chemistry638 nm gradually decreased and a shorter wavelength emission
at 560 nm appeared. Conversely, exposure of Mito-CM-BP to
GSH resulted in destruction of the p-conjugation between
coumarin and cyanoacetic acid. The inhibition of the ICT
process triggers a FRET-II process from the CM-GSH donor to
the BP acceptor, leading to a signicant uorescence
enhancement at lex ¼ 638 nm (lex ¼ 405 nm). Furthermore,
addition of SO2 breaks the conjugated system of the BP moiety,for the simultaneous detection of GSH and SO2.
Chem. Sci., 2021, 12, 3406–3426 | 3421
Scheme 30 The structure of probe AIE-mito-TPP and schematic
representation of intracellular tracking and the therapeutic effect of
AIE-mito-TPP in cancer cells. Reprinted from ref. 112. Copyright 2014,

























































































View Article Onlinewhich stops the FRET-II process, resulting in an increase in
emission at lem ¼ 494 nm and decrease in emission at lem ¼
638 nm. Importantly, Mito-CM-BP has been successfully used
for the visualization of enzymatic conversion of intracellular
GSH to SO2 in different cell lines (HepG2 and SW480 cells) and
tumour-bearing mice, which may help to clarify the metabolic
pathways of SO2 production and facilitate an understanding of
the role of SO2 in biological systems.
In 2018, Dhara et al. developed a lysosome targeting CO
uorescent probe LysoFP-NO2, consisting of a naphthalimide
uorophore, a nitro group as the CO responsive moiety, and
a morpholine fragment as the lysosome-targeting unit (Scheme
29).111 LysoFP-NO2 displayed weak uorescence due to the
strong electron withdrawing ability of the nitro group, which
can quench the uorescence of the uorophores by PeT.
However, upon the addition of CO, the nitro group was con-
verted into an amino moiety, stopping PeT and strengthening
the ICT process. Therefore, probe LysoFP-NO2 displayed a “turn
on” uorescence response towards CO with a 75-fold uores-
cence enhancement in HEPES buffer (1% DMSO, pH 7.4). In
addition, probe LysoFP-NO2 displayed high selectivity over
other relevant reactive nitrogen, oxygen, and sulfur species.
Moreover, LysoFP-NO2 could be used to monitor changes in
intracellular CO within the lysosomes of live MCF7 cells.
Liu et al. have developed a mitochondria-targeting probe
AIE-mito-TPP based on an AIE and ESIPT system as an imaging
agent and potential chemotherapeutic drug.112 Triphenylphos-
phonium (TPP), a positively charged lipophilic cation, is a well-
known mitochondrial targeting ligand due to the negative
potential gradient of the organelle.113 AIE-mito-TPP consists of
a salicylaldazine uorophore attached to two TPP groups for
targeting the mitochondria (Scheme 30). The salicylaldazine
uorophore uses two emission mechanisms: AIE via restriction
of intramolecular rotation around the N–N bond and ESIPT
caused by intramolecular hydrogen bonds. AIE-mito-TPP was
almost non-uorescent in cell-culture media but the uores-
cence due to both AIE and ESIPT is activated in mitochondria
(lex ¼ 543 nm, lem ¼ 575–625 nm). Furthermore, AIE-mito-TPP
accumulated preferably in cancer cell mitochondria and
exhibited selective cytotoxicity towards cancer cells which was
attributed to the difference in mitochondrial membrane
potential between normal and cancerous cells. In addition, AIE-
mito-TPP could induce mitochondrial dysfunction inuencingScheme 29 A lysosome targetable fluorescent probe LysoFP-NO2 for
detection of CO.
3422 | Chem. Sci., 2021, 12, 3406–3426several important cellular processes and facilitating the selec-
tive killing of HeLa cells.
As discussed in the section on ICT probes, b-gal is a known
biomarker for ovarian cancer. In 2019, Guo et al. reported
a probe for monitoring b-gal activity, designed around the
commonly used AIE quinoline–malononitrile uorophore.114 A
2-(2-hydroxyphenyl)benzothiazole moiety was conjugated to
both increase lipophilicity and extend the p-system to favour
NIR emission. A galactose residue was attached to the probe to
act as the recognition moiety, to give the probe QM-HBT-bgal.
In PBS solution (30% DMSO, v/v, pH 7.4) QM-HBT-bgal
produced a turn on response at lem ¼ 650 nm (lex ¼ 460 nm) in
the presence of b-gal. It was proposed that the saccharide
moiety of QM-HBT-bgal increased the hydrophilicity of theScheme 31 Detection of b-gal by combined AIE-ESIPT probe QM-
HBT-bgal.

























































































View Article Onlineprobe; and upon cleavage by b-gal, the resulting QM-HBT-OH
was insoluble in solution and aggregated to give an AIE
response (Scheme 31). Furthermore, cleavage of the sugar
moiety unmasks the ESIPT system upon formation of the
hydroxyl moiety. An increase in emission at 650 nm occurred,
scaling linearly, with added b-gal. Furthermore, the probe was
found to be highly selective (over other assayed enzymes and
amino acids), was stable over a pH range from 3 to 11, and
exhibited a 60-fold greater half-life than commercial standard
ICG. Due it is excellent performance in solution, QM-HBT-bgal
was then evaluated for the in vivo detection of b-gal. QM-HBT-
bgal exhibited no uorescence in HeLa cells without exogenous
addition of b-gal, whereas SKOV-3 cells exhibited signicant
uorescence enhancement with the probe due to high endog-
enous b-gal expression. Inhibition studies conrmed that the
AIE response originated from b-gal activity.
Recently, in 2020 the Tang group proposed an AIE lysosome
targeting probe for monitoring lysosomal pH during the tissue
regeneration process.115 Lysosomes play a key role in tissue
regeneration, for which pH 4–5 is essential for lysosomal
hydrolase activity. Whilst research has been conducted on
lysosomes and tissue regeneration, an in vivo study of lysosome
pH during the regeneration process had not previously been
reported. Probe CSMPP was designed around an a-cyanos-
tilbene uorophore, to which a piperazine moiety was attached
to target the lysosome. In solution (MeCN), CSMPP was found to
be weakly uorescent at lem ¼ 509 nm (lex ¼ 365 nm) but the
uorescence enhanced upon addition of water (MeCN/water, 2/
8, v/v) due to aggregation. By varying the pH of CSMPP in
solution, a ratiometric emission response was observed; relative
to neutral solutions, at acidic pH the emission band at lem ¼
509 nm decreased and a new emission at lem ¼ 615 nm
increased. The process was found to be reversible. The acid
sensitivity of the probe was ascribed to the piperazine and
pyridine moieties (Scheme 32). Furthermore, DFT calculations
indicated that protonation of the pyridine moiety afforded
enhanced ICT, imparting a ratiometric response upon proton-
ation. Staining of HeLa and ARPE-19 cells conrmed that
CSMPP could selectively target lysosomes, with PearsonScheme 32 Combined AIE-ICT probe CSMPP.
© 2021 The Author(s). Published by the Royal Society of Chemistrycoefficients of 0.92 and 0.90 respectively. In vivo NIR confocal
studies with medaka larvae indicated that CSMPP was able to
target lysosomes in the larval n with good specicity. CSMPP
was then used to study the regeneration process of injured
medaka caudal ns in vivo. Relative to a control group which
saw almost no lysosomal pH change, healing caudal ns were
shown to undergo a range of pH changes post-amputation.
Within 24 h, the pH dropped from 5.1 to 4.6 due to increased
lysosomal activity. Interestingly, the pH of lysosomes adjacent
to the injury were found to be more acidic than those further
away. As the tissue regenerated, the pH returned to normal aer
5 days.
Compared to single sensing mechanism-based sensors,
dual/triple sensing mechanism-based sensors generally
produce changes in the emission intensity and wavelength of
the signals at the same time, which can provide different uo-
rescence signals or amplify the response signals.16 This is highly
desirable for the simultaneous monitoring of multiple analytes
or improving the selectivity and sensitivity of uorescence
sensors. Furthermore, the signal-to-noise ratio would signi-
cantly increase when the two/multiple mechanisms have
similar effects on the same chromophore. We anticipate that
dual and multi mechanism based uorescent sensors will be
employed for exciting applications in various elds, especially
in high signal-to-noise ratio uorescence bioimaging, investi-
gating interactions among multiple biological species, and the
development of optical logic devices with multiple inputs and
outputs.
8. Conclusions
Over the last decade there have been considerable advances in
the development of molecular uorescent probes used for bio-
logical sensing and imaging, advancing our understanding and
guiding our treatment of a diverse range of medical conditions.
In particular, the development of high-resolution techniques
including STORM, PALM and PAI etc. have invigorated the area
by encouraging the de novo design of probes with improved
photophysical properties and targeting ability. With this
perspective we have highlighted some of the recent develop-
ments made in the design of such uorescent probes, using the
following approaches: FRET; ICT; PeT; ESIPT; AIE and probes
combining these modalities. Each probe has been selected
based on its ability (or potential), for detecting analytes of
interest in a real-world environment. In addition, we have
highlighted the advantages and disadvantages of each uores-
cence based approach. We end with a section outlining how
some disadvantages of individual uorescence based systems
can be overcome through the combination of multiple uores-
cence techniques.
In summary, with this perspective we believe we have high-
lighted recent progress made in the development of uorescent
probes using singular and multiple modality uorescence
approaches. From this perspective, it is clear that the area of
uorescent probes used for biological applications will
continue to be challenged and pushed forward by the develop-

























































































View Article Onlineimproved photophysical properties and targeting ability,
beyond what is currently available.
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